152 related articles for article (PubMed ID: 360647)
1. [Effect of portocaval shunt and arterialization of the liver on antibodies to Escherichia coli in patients with cirrhosis of the liver (author's transl)].
Schneider K; Penner E; Gangl A; Rotter M; Grabner G
Z Gastroenterol; 1978 Oct; 16(10):645-51. PubMed ID: 360647
[TBL] [Abstract][Full Text] [Related]
2. [The effect of liver arterialization on the regeneration process of the cirrhotic rat liver].
Brölsch CE
Chir Forum Exp Klin Forsch; 1978; (1978):197-201. PubMed ID: 752587
[TBL] [Abstract][Full Text] [Related]
3. [Does flow-limited portal arterialization avoid the disadvantages of portacaval shunts in healthy and cirrhotic rats? (author's transl)].
Hirner A; Häring R; Karavias T
Chir Forum Exp Klin Forsch; 1980; ():155-9. PubMed ID: 7389447
[TBL] [Abstract][Full Text] [Related]
4. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
Orloff MJ; Orloff MS; Orloff SL; Girard B
J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
[TBL] [Abstract][Full Text] [Related]
5. Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis.
Prytz H; Holst-Christensen J; Korner B; Liehr H
Scand J Gastroenterol; 1976; 11(8):857-63. PubMed ID: 794999
[TBL] [Abstract][Full Text] [Related]
6. [Late results (10 years) after complete arterialization of the cirrhotic liver].
Burlui D; Raţiu O
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1978; 27(3):209-12. PubMed ID: 694072
[TBL] [Abstract][Full Text] [Related]
7. [Immunoglobulins and non-organ-specific antibodies in alcoholic liver cirrhosis].
Maradona Hidalgo JA; Arribas Castrillo JM
Med Clin (Barc); 1981 Feb; 76(4):154-7. PubMed ID: 6970867
[TBL] [Abstract][Full Text] [Related]
8. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver.
Fierer J; Finley F
J Clin Invest; 1979 May; 63(5):912-921. PubMed ID: 376551
[TBL] [Abstract][Full Text] [Related]
9. [Quantitative changes of portal and arterial blood supply of the liver following porta-systemic shunting procedures (author's transl)].
Brölsch C; Grün M; Neuhaus P; Andreczewski W
Chir Forum Exp Klin Forsch; 1980; ():161-5. PubMed ID: 7389448
[TBL] [Abstract][Full Text] [Related]
10. Glucose tolerance after portacaval shunt in liver cirrhosis.
Pezzarossa A; Contini S; Bonora E; Marni A; Colotto G; Capocasale E; Butturini U
Diabete Metab; 1986 Aug; 12(4):197-202. PubMed ID: 3533668
[TBL] [Abstract][Full Text] [Related]
11. [Angiographic control of portocaval anastomoses. A study of hepato-portal circulatory changes after shunt (author's transl)].
Possati L; Cavallari A; Mazziotti A; Antonini L; Roversi RA; Rossi C
J Radiol; 1981; 62(6-7):351-61. PubMed ID: 7288733
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to Escherichia coli in chronic liver diseases.
Simjee AE; Hamilton-Miller JM; Thomas HC; Brumfitt W; Sherlock S
Gut; 1975 Nov; 16(11):871-5. PubMed ID: 1104410
[TBL] [Abstract][Full Text] [Related]
13. [Hepatic function and significance of the increase in serum concentrations of IgA in alcoholic cirrhosis].
Calmus Y; Poupon R; Barbare JC; Johanet C; Nédélec P; Darnis F
Gastroenterol Clin Biol; 1985; 9(8-9):614-6. PubMed ID: 4076720
[TBL] [Abstract][Full Text] [Related]
14. Arterialization of the liver after portacaval shunt in the rabbit.
Vassanelli P; Zannini P; Merigliano S; Maruotti RA
Int Surg; 1980; 65(2):151-5. PubMed ID: 7216658
[TBL] [Abstract][Full Text] [Related]
15. [Quantitative serum immunoglobulin determination: differential diagnostic significance for liver disease (author's transl)s].
Kleinschmidt J; Schlicht I
Med Klin; 1977 Mar; 72(12):505-12. PubMed ID: 840124
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to Escherichia coli in alcoholic and non-alcoholic patients with cirrhosis of the liver or fatty liver.
Prytz H; Björneboe M; Orskov F; Hilden M
Scand J Gastroenterol; 1973; 8(5):433-8. PubMed ID: 4584759
[No Abstract] [Full Text] [Related]
17. Hepatic [14C]aminopyrine demethylation capacity after portocaval shunting. Comparative study in patients with and without arterialization of portal vein.
Horsmans Y; Lejeune D; Geubel AP; Otte JB; Pauwels S
Dig Dis Sci; 1993 Dec; 38(12):2177-82. PubMed ID: 8261817
[TBL] [Abstract][Full Text] [Related]
18. Small-diameter H-graft portacaval shunt reduces portal flow yet maintains effective hepatic blood flow.
Zervos EE; Goode SE; Rosemurgy AS
Am Surg; 1998 Jan; 64(1):71-5; discussion 75-6. PubMed ID: 9457041
[TBL] [Abstract][Full Text] [Related]
19. [Hemodynamic studies on liver circulation with special reference to the hepatic artery].
Thiel H
Fortschr Med; 1977 Jul; 95(27):1741-4. PubMed ID: 903058
[TBL] [Abstract][Full Text] [Related]
20. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
Shurberg JL; Resnick RH; Koff RS; Ros E; Baum RA; Pallotta JA
Gastroenterology; 1977 Feb; 72(2):301-4. PubMed ID: 830579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
